Aralez Pharmaceuticals (ARLZ) Sank To Nearly A 52-Week Low After Q4 Loss

Aralez Pharmaceuticals (ARLZ) reported a fourth quarter GAAP loss of $0.48 per share Monday morning, compared to the loss of $0.40 per share last year.

from RTT - Before the Bell http://ift.tt/2mHNcky
via IFTTT